Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial (EC 1.14.15.18) (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase) (VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1)

 CP27B_HUMAN             Reviewed;         508 AA.
O15528; B2RC61; Q548T3;
15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
01-JAN-1998, sequence version 1.
05-DEC-2018, entry version 176.
RecName: Full=25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial;
EC=1.14.15.18 {ECO:0000269|PubMed:10518789};
AltName: Full=25-OHD-1 alpha-hydroxylase;
AltName: Full=25-hydroxyvitamin D(3) 1-alpha-hydroxylase;
Short=VD3 1A hydroxylase;
AltName: Full=Calcidiol 1-monooxygenase;
AltName: Full=Cytochrome P450 subfamily XXVIIB polypeptide 1;
AltName: Full=Cytochrome P450C1 alpha;
AltName: Full=Cytochrome P450VD1-alpha;
AltName: Full=Cytochrome p450 27B1;
Flags: Precursor;
Name=CYP27B1; Synonyms=CYP1ALPHA, CYP27B;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=9428799; DOI=10.1089/dna.1997.16.1499;
Fu G.K., Portale A.P., Miller W.L.;
"Complete structure of the human gene for the vitamin D 1alpha-
hydroxylase, P450c1alpha.";
DNA Cell Biol. 16:1499-1507(1997).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
TISSUE=Kidney;
PubMed=9344864; DOI=10.1006/bbrc.1997.7508;
Monkawa T., Yoshida T., Wakino S., Shinki T., Anazawa H., Deluca H.F.,
Suda T., Hayashi M., Saruta T.;
"Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin
D3 1 alpha-hydroxylase.";
Biochem. Biophys. Res. Commun. 239:527-533(1997).
[3]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=9415400; DOI=10.1210/mend.11.13.0035;
Fu G.K., Lin D., Zhang Y.H., Bikle D.D., Shackleton C.H., Miller W.L.,
Portale A.A.;
"Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and
mutations causing vitamin D-dependent rickets type 1.";
Mol. Endocrinol. 11:1961-1970(1997).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=12496369;
Huang D.C., Papavasiliou V., Rhim J.S., Horst R.L., Kremer R.;
"Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase
gene in ras-transformed keratinocytes demonstrates that locally
produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces
differentiation in an autocrine fashion.";
Mol. Cancer Res. 1:56-67(2002).
[5]
NUCLEOTIDE SEQUENCE [MRNA].
Huang D.C., Papavasiliou J., Rhim J., Kremer R.;
"Targeted disruption of the 25-hydroxyvitamin D3 1 a-hydroxylase gene
in a Ras-transformed human keratinocyte cell line: evidence for an
autocrine growth regulatory function of 1 alpha, 25-dihydroxyvitamin
D3 in vitro and in vivo.";
Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LEU-166.
NIEHS SNPs program;
Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Kidney;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[9]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[10]
FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
PubMed=10518789; DOI=10.1046/j.1432-1327.1999.00794.x;
Sawada N., Sakaki T., Kitanaka S., Takeyama K., Kato S., Inouye K.;
"Enzymatic properties of human 25-hydroxyvitamin D3 1alpha-hydroxylase
coexpression with adrenodoxin and NADPH-adrenodoxin reductase in
Escherichia coli.";
Eur. J. Biochem. 265:950-956(1999).
[11]
VARIANTS VDDR1A HIS-107; GLU-125; PRO-335 AND SER-382.
PubMed=9486994; DOI=10.1056/NEJM199803053381004;
Kitanaka S., Takeyama K., Murayama A., Sato T., Okumura K., Nogami M.,
Hasegawa Y., Niimi H., Yanagisawa J., Tanaka T., Kato S.;
"Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase
gene in patients with pseudovitamin D-deficiency rickets.";
N. Engl. J. Med. 338:653-661(1998).
[12]
VARIANTS VDDR1A HIS-65; LYS-189; HIS-389; ILE-409; PRO-429; CYS-453
AND ARG-497.
PubMed=9837822; DOI=10.1086/302156;
Wang J.T., Lin C.-J., Burridge S.M., Fu G.K., Labuda M., Portale A.A.,
Miller W.L.;
"Genetics of vitamin D 1-alpha-hydroxylase deficiency in 17
families.";
Am. J. Hum. Genet. 63:1694-1702(1998).
[13]
VARIANTS VDDR1A TYR-323 AND GLY-478.
PubMed=10320521; DOI=10.1359/jbmr.1999.14.5.730;
Smith S.J., Rucka A.K., Berry J.L., Davies M., Mylchreest S.,
Paterson C.R., Heath D.A., Tassabehji M., Read A.P., Mee A.P.,
Mawer E.B.;
"Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three
families with pseudovitamin D-deficiency rickets resulting in loss of
functional enzyme activity in blood-derived macrophages.";
J. Bone Miner. Res. 14:730-739(1999).
[14]
VARIANTS VDDR1A ARG-321 AND CYS-389.
PubMed=10566658; DOI=10.1210/jcem.84.11.6131;
Kitanaka S., Murayama A., Sakaki T., Inouye K., Seino Y., Fukumoto S.,
Shima M., Yukizane S., Takayanagi M., Niimi H., Takeyama K., Kato S.;
"No enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene
product in pseudovitamin D deficiency rickets, including that with
mild clinical manifestation.";
J. Clin. Endocrinol. Metab. 84:4111-4117(1999).
[15]
VARIANTS VDDR1A GLY-189; PHE-343; GLY-389; HIS-389 AND ILE-409.
PubMed=12050193; DOI=10.1210/jcem.87.6.8534;
Wang X., Zhang M.Y., Miller W.L., Portale A.A.;
"Novel gene mutations in patients with 1alpha-hydroxylase deficiency
that confer partial enzyme activity in vitro.";
J. Clin. Endocrinol. Metab. 87:2424-2430(2002).
-!- FUNCTION: Catalyzes the conversion of 25-hydroxyvitamin D3
(25(OH)D3) to 1-alpha,25-dihydroxyvitamin D3 (1alpha,25(OH)(2)D3),
and of 24,25-dihydroxyvitamin D3 (24,25(OH)(2)D3) to 1-
alpha,24,25-trihydroxyvitamin D3 (1alpha,24,25(OH)(3)D3). Is also
active with 25-hydroxy-24-oxo-vitamin D3. Plays an important role
in normal bone growth, calcium metabolism, and tissue
differentiation. {ECO:0000269|PubMed:10518789}.
-!- CATALYTIC ACTIVITY:
Reaction=calcidiol + 2 H(+) + O2 + 2 reduced [adrenodoxin] =
calcitriol + H2O + 2 oxidized [adrenodoxin];
Xref=Rhea:RHEA:20573, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
ChEBI:CHEBI:17823, ChEBI:CHEBI:17933, ChEBI:CHEBI:33737,
ChEBI:CHEBI:33738; EC=1.14.15.18;
Evidence={ECO:0000269|PubMed:10518789};
-!- CATALYTIC ACTIVITY:
Reaction=2 H(+) + O2 + 2 reduced [adrenodoxin] + secalciferol =
calcitetrol + H2O + 2 oxidized [adrenodoxin];
Xref=Rhea:RHEA:49064, Rhea:RHEA-COMP:9998, Rhea:RHEA-COMP:9999,
ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
ChEBI:CHEBI:28818, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738,
ChEBI:CHEBI:47799; EC=1.14.15.18;
Evidence={ECO:0000269|PubMed:10518789};
-!- COFACTOR:
Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
-!- BIOPHYSICOCHEMICAL PROPERTIES:
Kinetic parameters:
KM=2.7 uM for 25-hydroxyvitamin D3
{ECO:0000269|PubMed:10518789};
KM=1.1 uM for 24,25-dihydroxyvitamin D3
{ECO:0000269|PubMed:10518789};
Vmax=3.9 pmol/min/mg enzyme with 25-hydroxyvitamin D3 as
substrate {ECO:0000269|PubMed:10518789};
Vmax=3.2 pmol/min/mg enzyme with 24,25-dihydroxyvitamin D3 as
substrate {ECO:0000269|PubMed:10518789};
-!- PATHWAY: Hormone biosynthesis; cholecalciferol biosynthesis.
-!- SUBCELLULAR LOCATION: Mitochondrion membrane.
-!- TISSUE SPECIFICITY: Kidney.
-!- DISEASE: Rickets vitamin D-dependent 1A (VDDR1A) [MIM:264700]: A
disorder caused by a selective deficiency of the active form of
vitamin D (1,25-dihydroxyvitamin D3) and resulting in defective
bone mineralization and clinical features of rickets.
{ECO:0000269|PubMed:10320521, ECO:0000269|PubMed:10566658,
ECO:0000269|PubMed:12050193, ECO:0000269|PubMed:9486994,
ECO:0000269|PubMed:9837822}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
-!- WEB RESOURCE: Name=NIEHS-SNPs;
URL="http://egp.gs.washington.edu/data/cyp27b1/";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AF027152; AAC51854.1; -; Genomic_DNA.
EMBL; AB005038; BAA23416.1; -; mRNA.
EMBL; AB005989; BAA22656.1; -; mRNA.
EMBL; AB005990; BAA22657.1; -; Genomic_DNA.
EMBL; AB006987; BAA23418.1; -; Genomic_DNA.
EMBL; AF020192; AAC51853.1; -; mRNA.
EMBL; AF256213; AAG00416.1; -; Genomic_DNA.
EMBL; AF246895; AAF64299.1; -; mRNA.
EMBL; AY288916; AAP31972.1; -; Genomic_DNA.
EMBL; AK314953; BAG37458.1; -; mRNA.
EMBL; CH471054; EAW97067.1; -; Genomic_DNA.
EMBL; BC136386; AAI36387.1; -; mRNA.
CCDS; CCDS8954.1; -.
PIR; JC5713; JC5713.
RefSeq; NP_000776.1; NM_000785.3.
UniGene; Hs.524528; -.
ProteinModelPortal; O15528; -.
SMR; O15528; -.
BioGrid; 107966; 3.
STRING; 9606.ENSP00000228606; -.
BindingDB; O15528; -.
ChEMBL; CHEMBL5993; -.
DrugBank; DB01436; Alfacalcidol.
DrugBank; DB00146; Calcidiol.
DrugBank; DB01285; Corticotropin.
DrugBank; DB00153; Ergocalciferol.
GuidetoPHARMACOLOGY; 1370; -.
SwissLipids; SLP:000001478; -.
PhosphoSitePlus; O15528; -.
BioMuta; CYP27B1; -.
EPD; O15528; -.
PaxDb; O15528; -.
PeptideAtlas; O15528; -.
PRIDE; O15528; -.
ProteomicsDB; 48734; -.
TopDownProteomics; O15528; -.
Ensembl; ENST00000228606; ENSP00000228606; ENSG00000111012.
GeneID; 1594; -.
KEGG; hsa:1594; -.
UCSC; uc001spz.2; human.
CTD; 1594; -.
DisGeNET; 1594; -.
EuPathDB; HostDB:ENSG00000111012.9; -.
GeneCards; CYP27B1; -.
H-InvDB; HIX0171662; -.
HGNC; HGNC:2606; CYP27B1.
MalaCards; CYP27B1; -.
MIM; 264700; phenotype.
MIM; 609506; gene.
neXtProt; NX_O15528; -.
OpenTargets; ENSG00000111012; -.
Orphanet; 289157; Hypocalcemic vitamin D-dependent rickets.
PharmGKB; PA27099; -.
eggNOG; KOG0159; Eukaryota.
eggNOG; COG2124; LUCA.
GeneTree; ENSGT00940000153297; -.
HOGENOM; HOG000253961; -.
HOVERGEN; HBG106909; -.
InParanoid; O15528; -.
KO; K07438; -.
OMA; NSWRFAP; -.
OrthoDB; EOG091G0MI3; -.
PhylomeDB; O15528; -.
TreeFam; TF105094; -.
BRENDA; 1.14.13.13; 2681.
Reactome; R-HSA-196791; Vitamin D (calciferol) metabolism.
Reactome; R-HSA-211916; Vitamins.
Reactome; R-HSA-5579014; Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A).
SIGNOR; O15528; -.
UniPathway; UPA00955; -.
GeneWiki; 25-Hydroxyvitamin_D3_1-alpha-hydroxylase; -.
GenomeRNAi; 1594; -.
PRO; PR:O15528; -.
Proteomes; UP000005640; Chromosome 12.
Bgee; ENSG00000111012; Expressed in 98 organ(s), highest expression level in adult mammalian kidney.
CleanEx; HS_CYP27B1; -.
ExpressionAtlas; O15528; baseline and differential.
Genevisible; O15528; HS.
GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
GO; GO:0005739; C:mitochondrion; ISS:BHF-UCL.
GO; GO:0004498; F:calcidiol 1-monooxygenase activity; IDA:BHF-UCL.
GO; GO:0020037; F:heme binding; IEA:InterPro.
GO; GO:0005506; F:iron ion binding; IEA:InterPro.
GO; GO:0030282; P:bone mineralization; IEP:BHF-UCL.
GO; GO:0036378; P:calcitriol biosynthetic process from calciol; IDA:BHF-UCL.
GO; GO:0055074; P:calcium ion homeostasis; IMP:BHF-UCL.
GO; GO:0006816; P:calcium ion transport; ISS:BHF-UCL.
GO; GO:0046697; P:decidualization; IEP:BHF-UCL.
GO; GO:0070314; P:G1 to G0 transition; IMP:BHF-UCL.
GO; GO:0010956; P:negative regulation of calcidiol 1-monooxygenase activity; IDA:BHF-UCL.
GO; GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL.
GO; GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL.
GO; GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:BHF-UCL.
GO; GO:0010980; P:positive regulation of vitamin D 24-hydroxylase activity; IDA:BHF-UCL.
GO; GO:0070564; P:positive regulation of vitamin D receptor signaling pathway; IDA:BHF-UCL.
GO; GO:0030500; P:regulation of bone mineralization; IMP:BHF-UCL.
GO; GO:0043627; P:response to estrogen; IEP:BHF-UCL.
GO; GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL.
GO; GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL.
GO; GO:0033280; P:response to vitamin D; IDA:BHF-UCL.
GO; GO:0042369; P:vitamin D catabolic process; IEA:Ensembl.
GO; GO:0042359; P:vitamin D metabolic process; IDA:BHF-UCL.
GO; GO:0006766; P:vitamin metabolic process; TAS:Reactome.
Gene3D; 1.10.630.10; -; 1.
InterPro; IPR001128; Cyt_P450.
InterPro; IPR017972; Cyt_P450_CS.
InterPro; IPR002401; Cyt_P450_E_grp-I.
InterPro; IPR036396; Cyt_P450_sf.
Pfam; PF00067; p450; 1.
PRINTS; PR00463; EP450I.
PRINTS; PR00385; P450.
SUPFAM; SSF48264; SSF48264; 1.
PROSITE; PS00086; CYTOCHROME_P450; 1.
1: Evidence at protein level;
Complete proteome; Disease mutation; Heme; Iron; Membrane;
Metal-binding; Mitochondrion; Monooxygenase; Oxidoreductase;
Polymorphism; Reference proteome; Transit peptide.
TRANSIT 1 ? Mitochondrion. {ECO:0000255}.
CHAIN ? 508 25-hydroxyvitamin D-1 alpha hydroxylase,
mitochondrial.
/FTId=PRO_0000003622.
METAL 455 455 Iron (heme axial ligand). {ECO:0000250}.
VARIANT 65 65 Q -> H (in VDDR1A; dbSNP:rs868704228).
{ECO:0000269|PubMed:9837822}.
/FTId=VAR_016969.
VARIANT 107 107 R -> H (in VDDR1A; complete loss of
activity; dbSNP:rs28934604).
{ECO:0000269|PubMed:9486994}.
/FTId=VAR_016952.
VARIANT 125 125 G -> E (in VDDR1A; complete loss of
activity; dbSNP:rs28934605).
{ECO:0000269|PubMed:9486994}.
/FTId=VAR_016953.
VARIANT 166 166 V -> L (in dbSNP:rs8176344).
{ECO:0000269|Ref.6}.
/FTId=VAR_018841.
VARIANT 189 189 E -> G (in VDDR1A; 22% of wild-type
activity; dbSNP:rs118204012).
{ECO:0000269|PubMed:12050193}.
/FTId=VAR_016954.
VARIANT 189 189 E -> K (in VDDR1A; 11% of wild-type
activity). {ECO:0000269|PubMed:9837822}.
/FTId=VAR_016967.
VARIANT 321 321 T -> R (in VDDR1A; complete loss of
activity; dbSNP:rs118204007).
{ECO:0000269|PubMed:10566658}.
/FTId=VAR_016955.
VARIANT 323 323 S -> Y (in VDDR1A).
{ECO:0000269|PubMed:10320521}.
/FTId=VAR_016970.
VARIANT 335 335 R -> P (in VDDR1A; complete loss of
activity; dbSNP:rs28934606).
{ECO:0000269|PubMed:9486994}.
/FTId=VAR_016956.
VARIANT 343 343 L -> F (in VDDR1A; 2.3% of wild-type
activity; dbSNP:rs118204011).
{ECO:0000269|PubMed:12050193}.
/FTId=VAR_016957.
VARIANT 382 382 P -> S (in VDDR1A; complete loss of
activity; dbSNP:rs28934607).
{ECO:0000269|PubMed:9486994}.
/FTId=VAR_016958.
VARIANT 389 389 R -> C (in VDDR1A; complete loss of
activity; dbSNP:rs118204010).
{ECO:0000269|PubMed:10566658}.
/FTId=VAR_016968.
VARIANT 389 389 R -> G (in VDDR1A; complete loss of
activity; dbSNP:rs118204010).
{ECO:0000269|PubMed:12050193}.
/FTId=VAR_016960.
VARIANT 389 389 R -> H (in VDDR1A; complete loss of
activity; dbSNP:rs118204009).
{ECO:0000269|PubMed:12050193,
ECO:0000269|PubMed:9837822}.
/FTId=VAR_016959.
VARIANT 409 409 T -> I (in VDDR1A; dbSNP:rs118204008).
{ECO:0000269|PubMed:12050193,
ECO:0000269|PubMed:9837822}.
/FTId=VAR_016961.
VARIANT 429 429 R -> P (in VDDR1A; dbSNP:rs568165874).
{ECO:0000269|PubMed:9837822}.
/FTId=VAR_016971.
VARIANT 453 453 R -> C (in VDDR1A; dbSNP:rs767480544).
{ECO:0000269|PubMed:9837822}.
/FTId=VAR_016972.
VARIANT 478 478 V -> G (in VDDR1A).
{ECO:0000269|PubMed:10320521}.
/FTId=VAR_016973.
VARIANT 497 497 P -> R (in VDDR1A).
{ECO:0000269|PubMed:9837822}.
/FTId=VAR_016974.
CONFLICT 320 320 D -> N (in Ref. 7; BAG37458).
{ECO:0000305}.
SEQUENCE 508 AA; 56504 MW; 7F0611EFAD1B5C1C CRC64;
MTQTLKYASR VFHRVRWAPE LGASLGYREY HSARRSLADI PGPSTPSFLA ELFCKGGLSR
LHELQVQGAA HFGPVWLASF GTVRTVYVAA PALVEELLRQ EGPRPERCSF SPWTEHRRCR
QRACGLLTAE GEEWQRLRSL LAPLLLRPQA AARYAGTLNN VVCDLVRRLR RQRGRGTGPP
ALVRDVAGEF YKFGLEGIAA VLLGSRLGCL EAQVPPDTET FIRAVGSVFV STLLTMAMPH
WLRHLVPGPW GRLCRDWDQM FAFAQRHVER REAEAAMRNG GQPEKDLESG AHLTHFLFRE
ELPAQSILGN VTELLLAGVD TVSNTLSWAL YELSRHPEVQ TALHSEITAA LSPGSSAYPS
ATVLSQLPLL KAVVKEVLRL YPVVPGNSRV PDKDIHVGDY IIPKNTLVTL CHYATSRDPA
QFPEPNSFRP ARWLGEGPTP HPFASLPFGF GKRSCMGRRL AELELQMALA QILTHFEVQP
EPGAAPVRPK TRTVLVPERS INLQFLDR


Related products :

Catalog number Product name Quantity
EIAAB08889 25-hydroxyvitamin D(3) 1-alpha-hydroxylase,25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial,25-OHD-1 alpha-hydroxylase,Calcidiol 1-monooxygenase,Cyp27b,Cyp27b1,Cytochrome p450 27B1,Cytochrome P4
EIAAB08887 25-hydroxyvitamin D(3) 1-alpha-hydroxylase,25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial,25-OHD-1 alpha-hydroxylase,Calcidiol 1-monooxygenase,Cyp27b,Cyp27b1,Cyp40,Cytochrome p450 27B1,Cytochr
EIAAB08888 25-hydroxyvitamin D(3) 1-alpha-hydroxylase,25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial,25-OHD-1 alpha-hydroxylase,Calcidiol 1-monooxygenase,CYP1ALPHA,CYP27B,CYP27B1,Cytochrome p450 27B1,Cyt
EIAAB08884 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase,CYP27,CYP27A1,Cytochrome P450 27,Cytochrome P-450C27_25,Homo sapiens,Human,Sterol 26-hydroxylase, mitochondrial,Sterol 27-hydroxylase,Vi
EIAAB08885 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase,Cyp27,Cyp27a1,Cytochrome P450 27,Cytochrome P-450C27_25,Rat,Rattus norvegicus,Sterol 26-hydroxylase, mitochondrial,Sterol 27-hydroxylase
EIAAB08883 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase,Cyp27a1,Cytochrome P450 27,Cytochrome P-450C27_25,Mouse,Mus musculus,Sterol 26-hydroxylase, mitochondrial,Sterol 27-hydroxylase,Vitamin
EIAAB09037 7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,CYP12,CYP8B1,CYPVIIIB1,Cytochrome P450 8B1,Homo sapiens,Human,Sterol 12-alpha-hydroxylase
EIAAB09038 7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,Cyp12,Cyp8b1,CYPVIIIB1,Cytochrome P450 8B1,Mouse,Mus musculus,Sterol 12-alpha-hydroxylase
EIAAB08908 Cyp2b10,Cyp2b-10,Cyp2b20,CYPIIB10,CYPIIB20,Cytochrome P450 2B10,Cytochrome P450 2B20,Cytochrome P450 clone PF3_46,Cytochrome P450-16-alpha,Mouse,Mus musculus,P24,Testosterone 16-alpha hydroxylase
EIAAB08886 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase,CYP27,CYP27A1,Cytochrome P450 27,Cytochrome P-450C27_25,Oryctolagus cuniculus,Rabbit,Sterol 26-hydroxylase, mitochondrial,Sterol 27-hydr
EIAAB08890 Cyp2a1,Cyp2a-1,CYPIIA1,Cytochrome P450 2A1,Cytochrome P450-UT-F,Rat,Rattus norvegicus,Steroid hormones 7-alpha-hydroxylase,Testosterone 7-alpha-hydroxylase
EIAAB09039 7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,CYP12,CYP8B1,CYPVIIIB1,Cytochrome P450 8B1,Oryctolagus cuniculus,Rabbit,Sterol 12-alpha-hy
EIAAB08907 Cyp2b9,Cyp2b-9,CYPIIB9,Cytochrome P450 2B9,Cytochrome P450 clone PF26,Cytochrome P450-16-alpha,Mouse,Mus musculus,Rip,Testosterone 16-alpha hydroxylase
EIAAB08893 Cyp2a4,Cyp2a-4,CYPIIA4,Cytochrome P450 2A4,Cytochrome P450-15-alpha,Cytochrome P450-IIA3.1,Mouse,Mus musculus,Testosterone 15-alpha-hydroxylase
EIAAB08940 Cyp2d10,Cyp2d-10,CYPIID10,Cytochrome P450 2D10,Cytochrome P450-16-alpha,Cytochrome P450CB,Mouse,Mus musculus,Testosterone 16-alpha hydroxylase
EIAAB08941 Cyp2d11,Cyp2d-11,CYPIID11,Cytochrome P450 2D11,Cytochrome P450-16-alpha,Cytochrome P450CC,Mouse,Mus musculus,Testosterone 16-alpha hydroxylase
EIAAB09040 5-beta-cholestane-3-alpha,7-alpha-diol 12-alpha-hydroxylase,CYP8B1,CYPVIIIB1,Cytochrome P450 8B1,Pig,Sterol 12-alpha-hydroxylase,Sus scrofa
EIAAB08938 Cyp2d9,Cyp2d-9,CYPIID9,Cytochrome P450 2D9,Cytochrome P450-16-alpha,Cytochrome P450CA,Mouse,Mus musculus,Testosterone 16-alpha hydroxylase
EIAAB09034 25-hydroxycholesterol 7-alpha-hydroxylase,CYP7B1,Cytochrome P450 7B1,Homo sapiens,Human,Oxysterol 7-alpha-hydroxylase
EIAAB08971 24-hydroxycholesterol 7-alpha-hydroxylase,Cyp39a1,Cytochrome P450 39A1,mCYP39A1,Mouse,Mus musculus,Oxysterol 7-alpha-hydroxylase
EIAAB08899 Cyp2a12,CYPIIA12,Cytochrome P450 2A12,Mouse,Mus musculus,Steroid hormones 7-alpha-hydroxylase,Testosterone 7-alpha-hydroxylase
EIAAB09035 25-hydroxycholesterol 7-alpha-hydroxylase,Cyp7b1,Cytochrome P450 7B1,HCT-1,Hippocampal transcript 1 protein,Oxysterol 7-alpha-hydroxylase,Rat,Rattus norvegicus
EIAAB08972 24-hydroxycholesterol 7-alpha-hydroxylase,CYP39A1,Cytochrome P450 39A1,hCYP39A1,Homo sapiens,Human,Oxysterol 7-alpha-hydroxylase
EIAAB09036 25-hydroxycholesterol 7-alpha-hydroxylase,Cyp7b1,Cytochrome P450 7B1,HCT-1,Hippocampal transcript 1 protein,Mouse,Mus musculus,Oxysterol 7-alpha-hydroxylase
E1557h ELISA kit 21-OHase,CYP21,CYP21A2,CYP21B,Cytochrome P450 21,Cytochrome P450 XXI,Cytochrome P-450c21,Cytochrome P450-C21,Cytochrome P450-C21B,Homo sapiens,Human,Steroid 21-hydroxylase 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur